KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$5.7 million.

  • Emergent BioSolutions' Free Cash Flow fell 10385.4% to -$5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 9898.62%. This contributed to the annual value of $35.8 million for FY2024, which is 11388.13% up from last year.
  • Emergent BioSolutions' Free Cash Flow amounted to -$5.7 million in Q3 2025, which was down 10385.4% from $103.5 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Free Cash Flow peaked at $282.3 million during Q4 2021, and registered a low of -$253.4 million during Q3 2022.
  • Over the past 5 years, Emergent BioSolutions' median Free Cash Flow value was -$38.5 million (recorded in 2021), while the average stood at -$16.9 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 55818.18% in 2022, then soared by 21202.53% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Free Cash Flow (Quarter) stood at $282.3 million in 2021, then crashed by 67.13% to $92.8 million in 2022, then crashed by 77.69% to $20.7 million in 2023, then crashed by 494.2% to -$81.6 million in 2024, then skyrocketed by 93.01% to -$5.7 million in 2025.
  • Its last three reported values are -$5.7 million in Q3 2025, $103.5 million for Q2 2025, and -$14.8 million during Q1 2025.